Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,204,699
-
Share change
-
+538,675
-
Total reported value
-
$3,825,603,063
-
Put/Call ratio
-
66%
-
Price per share
-
$131.00
-
Number of holders
-
164
-
Value change
-
+$72,353,478
-
Number of buys
-
76
-
Number of sells
-
65
Institutional Holders of KARUNA THERAPEUTICS INC - COM (KRTX) as of Q4 2021
As of 31 Dec 2021,
KARUNA THERAPEUTICS INC - COM (KRTX) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,204,699 shares.
The largest 10 holders included
FMR LLC, ARCH Venture Management, LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Sofinnova Investments, Inc., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, FEDERATED HERMES, INC., VIKING GLOBAL INVESTORS LP, and Pivotal bioVenture Partners Investment Advisor LLC.
This page lists
164
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.